Allografting

LifeNet Health announced the launch of the PliaFX Pak bone allografting solution, which was developed in collaboration with Johnson & Johnson, according to a company press release.

Published results showed meniscal allograft transplantation combined with arthroscopic intervention may delay the need for arthroplasty, as well as improve pain relief and function for patients initially recommended for knee arthroplasty.

Use of cryopreserved human umbilical cord tissue, known as Wharton’s jelly, may be an alternative treatment for tissue regeneration in patients with hip cartilage defects and osteoarthritis, according to published results.

Use of magnetic growing intramedullary nails in compression may yield a high union rate in intercalary allograft reconstruction, according to results presented at the Limb Lengthening and Reconstruction Society Annual Meeting.

Axogen Inc. announced the launch of the Avive+ soft tissue matrix for use as a barrier to protect and promote healing of the peripheral nerve after acute traumatic injury, according to a company press release.

Published results showed osteochondral allograft transplantation, autologous chondrocyte implantation and matrix-induced autologous chondrocyte implantation all yielded similar outcomes for patients with patellofemoral cartilage defects.

SAN FRANCISCO — Results presented here showed fresh osteochondral allograft transplantation yielded a low rate of complications and a high rate of return to sports in patients with unstable capitellar osteochondritis dissecans.

SAN FRANCISCO — Results presented here showed an association between older patient age, degenerative diagnosis and larger graft size with higher risk of failure after osteochondral allograft transplantation for articular cartilage lesions.

WAILEA, Hawaii — At Orthopedics Today Hawaii, Michael J. Stuart, MD, spoke about recommendations and techniques for meniscus allograft transplantation.

WASHINGTON — According to presented results, meniscal allograft transplantation provided predictable functional improvements for adolescent patients with functional outcomes and graft survivorship comparable to those in adults.